Abner Herrman & Brock LLC Amgen Inc Transaction History

Abner Herrman & Brock LLC

$829 Million
Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Amgen Inc stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 11,460 shares of AMGN stock, worth $3.63 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

11,460

Previous 11,163 2.66%

Holding current value

$3.63 Million

Previous $3.49 Million 5.85%

% of portfolio

0.45%

Previous 0.44%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $91,885 - $100,201	297 Added 2.66%	11,460 $3.69 Million
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $102,735 - $124,850	391 Added 3.63%	11,163 $3.49 Million
Q1 2024 Apr 09, 2024	BUY	$268.87 - $324.56 $219,129 - $264,516	815 Added 8.19%	10,772 $3.06 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $391,988 - $442,209	1,533 Added 18.2%	9,957 $2.87 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $543,345 - $674,578	2,485 Added 41.84%	8,424 $2.26 Million
Q2 2023 Jul 05, 2023	BUY	$214.27 - $253.37 $608,741 - $719,824	2,841 Added 91.7%	5,939 $1.32 Million
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $487,254 - $593,881	2,158 Added 229.57%	3,098 $749,000
Q4 2022 Jan 04, 2023	SELL	$229.03 - $291.01 $5,725 - $7,275	-25 Reduced 2.59%	940 $247,000
Q3 2022 Oct 06, 2022	BUY	$224.46 - $253.15 $216,603 - $244,289	965 New	965 $218,000
Q3 2021 Oct 06, 2021	SELL	$212.27 - $248.7 $230,949 - $270,585	-1,088 Closed	0 $0
Q1 2021 Apr 09, 2021	SELL	$221.91 - $258.6 $7,544 - $8,792	-34 Reduced 3.03%	1,088 $271,000
Q4 2020 Jan 12, 2021	BUY	$216.38 - $257.67 $9,737 - $11,595	45 Added 4.18%	1,122 $258,000
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $12,905 - $14,352	-55 Reduced 4.86%	1,077 $274,000
Q2 2020 Jul 10, 2020	BUY	$197.81 - $242.74 $1,186 - $1,456	6 Added 0.53%	1,132 $267,000
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $167,478 - $222,122	-919 Reduced 44.94%	1,126 $228,000
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $33,111 - $42,560	175 Added 9.36%	2,045 $493,000
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $17,759 - $21,279	-102 Reduced 5.17%	1,870 $362,000
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $185,870 - $217,882	-1,115 Reduced 36.12%	1,972 $363,000
Q1 2019 Apr 08, 2019	SELL	$180.87 - $203.88 $10.1 Million - $11.4 Million	-55,931 Reduced 94.77%	3,087 $586,000
Q4 2018 Jan 11, 2019	BUY	$178.4 - $208.25 $446,892 - $521,666	2,505 Added 4.43%	59,018 $11.5 Million
Q3 2018 Oct 19, 2018	BUY	$185.29 - $208.89 $680,384 - $767,044	3,672 Added 6.95%	56,513 $11.7 Million
Q2 2018 Jul 06, 2018	BUY	$166.05 - $186.51 $133,172 - $149,581	802 Added 1.54%	52,841 $9.75 Million
Q1 2018 Apr 06, 2018	BUY	$169.43 - $198.0 $735,834 - $859,914	4,343 Added 9.11%	52,039 $8.87 Million
Q4 2017 Jan 05, 2018	BUY	$168.79 - $188.59 $556,838 - $622,158	3,299 Added 7.43%	47,696 $8.29 Million
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $7.43 Million - $8.48 Million	44,397	44,397 $8.28 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Account

Abner Herrman & Brock LLC Amgen Inc Transaction History